Ultomiris is a medication used to treat paroxysmal nocturnal hemoglobinuria (PNH) in adults and children. PNH is a rare, life-threatening blood disorder in which the body destroys red blood cells, causing symptoms such as fatigue, shortness of breath, and chest pain.
Ultomiris works by inhibiting a part of the immune system called the complement system, which is overactive in individuals with PNH. By blocking this system, Ultomiris helps to prevent the destruction of red blood cells and improve symptoms associated with the disorder.
Ultomiris is typically administered intravenously every 8 weeks by a healthcare professional. Common side effects of Ultomiris may include headache, diarrhea, nausea, and upper respiratory infections. It is important to regularly monitor patients receiving Ultomiris for any signs of infection or other complications.
As with any medication, it is important to discuss the potential benefits and risks of Ultomiris with a healthcare provider before starting treatment. It is also important to follow the dosage instructions provided by the healthcare provider to ensure the medication is effective and safe.
Ne Demek sitesindeki bilgiler kullanıcılar vasıtasıyla veya otomatik oluşturulmuştur. Buradaki bilgilerin doğru olduğu garanti edilmez. Düzeltilmesi gereken bilgi olduğunu düşünüyorsanız bizimle iletişime geçiniz. Her türlü görüş, destek ve önerileriniz için iletisim@nedemek.page